Penumbra, Inc.PEN
NYSE•Healthcare•Medical Devices
Analyze revenue and earnings growth — the core drivers of long-term shareholder returns.
TTM revenue reached $1.45B, growing 17.3% year-over-year. TTM net income stood at $171.05M (305.0% growth). Quarterly EBITDA was $42.81M and operating income was $38.23M. Consistent revenue and earnings growth are the primary drivers of long-term shareholder returns. Analyze PEN growth trends across revenue, EBITDA, operating income, and net income.
Revenue and earnings growth across quarters